Featured Research

from universities, journals, and other organizations

Fattening gene discovered by researchers

Date:
April 30, 2014
Source:
Max-Planck-Gesellschaft
Summary:
The long-term consumption of too much high-energy and high-fat food leads to overweight. Behind this trivial statement lies the extremely complex regulation of lipid metabolism. Now, a gene that controls fat metabolism has been discovered by researchers who hope that their study will provide the basis for new therapeutic approaches.

Fatty liver with SIRT7. The microscope images show the liver tissue of control animals (left) and mice that lack the SIRT7 gene magnified by a factor of 400. Whereas the control animals form large numbers of fat depots when fed a high-fat diet, the SIRT7-knockout mice do not develop fatty liver.
Credit: © MPI f. Heart and Lung Research

The long-term consumption of too much high-energy and high-fat food leads to overweight. Behind this trivial statement lies the extremely complex regulation of lipid metabolism. Together with colleagues from Japan, scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now discovered that the Sirt7 gene plays a central role in energy metabolism. Despite consuming high-fat food, genetically modified mice that lack the gene maintain their normal weight.

Food was not always available to such excess as it is in western societies today. On the contrary, our metabolism was tailored to the optimum exploitation of energy, as humans, for millennia, had to budget their calories carefully. Thus, the formation and depletion of fat depots as energy stores is subject to complex regulation. A series of regulators is involved in lipid metabolism in the liver for the purpose of storing excess energy and making it available again when required.

Working in cooperation with colleagues from the Sendai and Kumamoto Universities in Japan, scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now identified a protein from the sirtuin group that plays a major role in the utilization of energy in the context of a high-fat diet and is responsible for the formation of fat depots. Sirtuins are known as a group of proteins with wide-ranging biological functions.

The researchers carried out their tests on mice which lack a sirtuin known as SIRT7. These Sirt7-knockout mice and non-genetically-modified animals were fed particularly high-fat pellets for months. "We established that Sirt7-knockout mice put on significantly less weight than the control group. On the contrary, they maintained their normal weight," says Eva Bober, a scientist at the MPI. Moreover, compared with the non-genetically-modified mice, these animals tended to have lower triglyceride and cholesterol levels in their livers and normal insulin levels. "Everything pointed to the fact that the animals which lacked SIRT7 were able to process the excess energy in the food better and did not build up any pathological fat depots," says Bober.

To investigate the molecular processes behind this observation, the scientists studied the gene activities of the liver cells. In the process, it emerged that SIRT7 activates the expression of a large number of genes for lipid metabolism. In the liver cells from mice without SIRT7, this gene remains largely unactivated and fewer fat depots are formed as a result.

"We discovered a second mechanism as well," says Bober. "SIRT7 also inhibits the degradation of certain proteins. Because they are then active for longer, these proteins also make a greater contribution to energy storage than is actually intended." Conversely, if SIRT7 is missing, these proteins are degraded and fewer fat depots are formed.

The researchers hope that their study will provide the basis for new therapeutic approaches. "We would now like to examine substances with which the function of SIRT7 can be deliberately inhibited. We want to examine whether the same effects arise as observed in the mice that lack the Sirt7 gene," explains Bober. The long-term objective is the development of a drug that would reduce the efficiency of lipid metabolism. This would enable the avoidance of overweight.


Story Source:

The above story is based on materials provided by Max-Planck-Gesellschaft. Note: Materials may be edited for content and length.


Journal Reference:

  1. Tatsuya Yoshizawa, Md. Fazlul Karim, Yoshifumi Sato, Takafumi Senokuchi, Keishi Miyata, Takaichi Fukuda, Chisa Go, Masayoshi Tasaki, Kohei Uchimura, Tsuyoshi Kadomatsu, Zhe Tian, Christian Smolka, Tomohiro Sawa, Motohiro Takeya, Kazuhito Tomizawa, Yukio Ando, Eiichi Araki, Takaaki Akaike, Thomas Braun, Yuichi Oike, Eva Bober, Kazuya Yamagata. SIRT7 Controls Hepatic Lipid Metabolism by Regulating the Ubiquitin-Proteasome Pathway. Cell Metabolism, 2014; 19 (4): 712 DOI: 10.1016/j.cmet.2014.03.006

Cite This Page:

Max-Planck-Gesellschaft. "Fattening gene discovered by researchers." ScienceDaily. ScienceDaily, 30 April 2014. <www.sciencedaily.com/releases/2014/04/140430133147.htm>.
Max-Planck-Gesellschaft. (2014, April 30). Fattening gene discovered by researchers. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/04/140430133147.htm
Max-Planck-Gesellschaft. "Fattening gene discovered by researchers." ScienceDaily. www.sciencedaily.com/releases/2014/04/140430133147.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins